Skip to main content

IRB Committee 1

IRB Committee 1 is responsible for the full review of human subjects research protocols submitted by faculty/staff for all colleges except the C.T. Bauer School of Business and the College of Liberal Arts and Social Sciences (CLASS). Exceptions: The HHP Department of CLASS submits to IRB 1; all FDA-regulated research is also reviewed by IRB 1, regardless of college.

Full Committee

Submission Deadlines Meeting Dates*
Friday, September 2, 2016 Friday, September 16, 2016
Friday, October 7, 2016 Friday, October 21, 2016
Friday, November 4, 2016 Friday, November 18, 2016
Friday, November 23, 2016 Friday, December 9, 2016
Friday, January 6, 2017 Friday, January 20, 2017
Monday, February 3, 2017 Friday, February 17, 2017
Friday, March 10, 2017 Friday, March 24, 2017
Friday, April 7, 2017 Friday, April 21, 2017
Friday, May 5, 2017 Friday, May 19, 2017
Friday, June 2, 2017 Friday, June 16, 2017
Friday, July 7, 2017 Friday, July 21, 2017
Friday, August 4, 2017 Friday, August 18, 2017

*Dates are subject to change without notice if circumstances require rescheduling.

Expedited Review 

Protocols falling under an expedited category and involving no more than minimal risk, as well as minor changes in approved full board protocols, may be reviewed under an expedited process. The Chair of IRB 1 either reviews or delegates the review to one or more experienced IRB members, who review the protocol under applicable regulations and either approve or require modifications to the protocol prior to approval. An expedited reviewer may not disapprove a protocol, but may forward to the fully convened committee for further determination if warranted. Expedited submissions are considered on a rolling basis, thus turnaround time for these submissions is expected to be quicker than for protocols undergoing full board review.  

Exempt Status

Protocols falling under an exempt category defined under the federal regulations require administrative review by the IRB office to ensure that basic ethical principles, such as confidentiality of data and obtaining informed consent where applicable, are addressed. Applications for exempt protocols are reviewed by IRB staff on a rolling basis, thus turnaround time for these submissions is expected to be quicker than for protocols undergoing full board review.